Non-Bacterial Thrombotic Endocarditis in a Patient with Rheumatoid Arthritis |
Choi, Jung-Hye
(Department of Rheumatology, Yonsei University Wonju College of Medicine)
Park, Jeong-Eun (Department of Rheumatology, Yonsei University Wonju College of Medicine) Kim, Jang-Young (Department of Cardiology, Yonsei University Wonju College of Medicine) Kang, Taeyoung (Department of Rheumatology, Yonsei University Wonju College of Medicine) |
1 | Eiken PW, Edwards WD, Tazelaar HD, McBane RD, Zehr KJ. Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000. Mayo Clin Proc 2001;76:1204-12. DOI |
2 | Meune C, Touze E, Trinquart L, Allanore Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2009;48:1309-13. DOI |
3 | Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7. DOI |
4 | el-Shami K, Griffiths E, Streiff M. Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment. Oncologist 2007;12:518-23. DOI |
5 | Turiel M, Sitia S, Atzeni F, et al. The heart in rheumatoid arthritis. Autoimmun Rev 2010;9:414-8. DOI |
6 | Wislowska M, Sypula S, Kowalik I. Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease. Clin Rheumatol 1998;17:369-77. DOI |
7 | Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008;59:1690-7. DOI |
8 | Baghdadi LR, Woodman RJ, Shanahan EM, Mangoni AA. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS One 2015;10:e0117952. DOI |
9 | Kim SC, Solomon DH, Liu J, Franklin JM, Glynn RJ, Schneeweiss S. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs. Am J Med 2014;128:539.e7-17. |
10 | Chatzis A, Giannopoulos N, Baharakakis S, Saridakis N, Agapitos E, Stamatelopoulos S. Unusual cause of a stroke in a patient with seronegative rheumatoid arthritis. Cardiovasc Surg 1999;7:659-60. DOI |
11 | Mounet F, Soula P, Concina P, Baradat G, Cerene A. [Heart valve diseases specific in rheumatoid polyarthritis. Apropos of 2 cases]. Arch Mal Coeur Vaiss 1997;90:987-9. |
12 | Kang H, Baron M. Embolic complications of a mitral valve rheumatoid nodule. J Rheumatol 2004;31:1001-3. |
13 | Choi HK, Rho YH, Zhu Y, Cea-Soriano L, Avina-Zubieta JA, Zhang Y. The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann Rheum Dis 2013;72:1182-7. DOI |
14 | Bacani AK, Gabriel SE, Crowson CS, Heit JA, Matteson EL. Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum 2012;64:53-61. DOI |
15 | van der Poll T, Büller HR, ten Cate H, et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990;322:1622-7. DOI |
16 | Ong ML, Veerapen K, Chambers JB, Lim MN, Manivasagar M, Wang F. Cardiac abnormalities in systemic lupus erythematosus: prevalence and relationship to disease activity. Int J Cardiol 1992;34:69-74. DOI |
17 | Mazokopakis EE, Syros PK, Starakis IK. Nonbacterial thrombotic endocarditis (marantic endocarditis) in cancer patients. Cardiovasc Hematol Disord Drug Targets 2010;10:84-6. DOI |